Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Aug 10, 2011

Premium

The National Institutes of Health has tapped Mahendra Rao to be director of the new Intramural Center for Regenerative Medicine (CRM). Rao formerly was VP of regenerative medicine at Life Technologies and he co-founded the neural stem cell company Q-Therapeutics. The NIH-CRM is an initiative to create a center of excellence in stem cell technology located at NIH's campus that will focus on studying and using induced pluripotent stem cells.

Rao had joined Life Tech predecessor Invitrogen in 2006 after serving as section chief for stem cells and senior investigator in the laboratory of neuroscience for the National Institute on Aging.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.